高同型半胱氨酸对合并非瓣膜性心房颤动的急性脑梗死患者近期预后的影响

doi:10.3969/j.issn.1673-5765.2020.11.007

摘要/Abstract

摘要：

目的探讨同型半胱氨酸（homocysteine，Hcy）对合并非瓣膜性心房颤动的急性脑梗死患者近期预后的影响。方法前瞻性连续纳入合并非瓣膜性心房颤动的急性脑梗死的住院患者，所有患者均在发病48 h 内住院。收集患者的基线临床资料及相关实验室检查结果。随访患者发病90 d时临床预后，良好预后定义为mRS评分≤2分。采用多因素Logistic回归分析，探讨合并非瓣膜性心房颤动的急性脑梗死患者 90 d预后的独立影响因素。结果共纳入患者112例，男性46例（41.1%），年龄45～92岁，平均76.23±9.02岁。其中良好预后患者53例（47.3%）。多因素回归分析显示，入院时NIHSS评分高（OR 1.632，95%CI 1.185～2.250， P =0.03）、高血糖（OR 1.360，95%CI 1.052～1.758，P =0.019）、高Hcy水平（OR 1.702，95%CI 1.133～2.557，P =0.010）是影响患者90 d预后的独立危险因素。结论高Hcy是合并非瓣膜性心房颤动的急性脑梗死患者短期不良预后的独立影响因素。

文章导读： 本研究发现高同型半胱氨酸血症是非瓣膜性心房颤动的急性脑梗死患者短期结局不良的独立影响因素，为脑梗死的防治和评估预后提供一定的依据。

关键词: 急性脑梗死; 心房颤动; 同型半胱氨酸; 预后

Abstract:

Objective To explore the impact of hyperhomocysteine on short-term outcome in acute cerebral infarction (ACI) patients with non-valvular atrial fibrillation (AF). Methods This prospective study consecutively enrolled ACI inpatients within 48 hours of stroke onset and with no-valvular AF. Baseline clinical data and relevant laboratory test results were collected. The primary outcome was a mRS score at 90 days. Good outcome was defined as a mRS score of 0-2. Multivariate logistic regression analysis was performed to determine the independent risk factors for 90-day outcome. Results A total of 112 patients were included, with 46 males (41.4%) and a mean age of 76.23±9.02 years old (range: 45-92 years old). 53 (47.3%) patients had good prognosis. Multivariate logistic regression analysis showed that higher NIHSS score at admission (OR 1.632, 95%CI 1.185-2.250, P =0.03), hyperglycemia (OR 1.360, 95%CI 1.052-1.758, P =0.019) and higher homocysteine (OR 1.702, 95%CI 1.133-2.557, P =0.010) were independent risk factors for 90-day clinical outcome. Conclusions Hyperhomocysteine may be an independent risk factor for 90-day outcome in ACI patients with non-valvular AF.

Key words: Acute cerebral infarction; Atrial fibrillation; Homocysteine; Outcome

陈黔妹，刘芳，盛灿，吴大鹏，刘佳琪. 高同型半胱氨酸对合并非瓣膜性心房颤动的急性脑梗死患者近期预后的影响[J]. 中国卒中杂志, 2020, 15(11): 1192-1197.

CHEN Qian-Mei, LIU Fang, Sheng Can, WU Da-Peng, LIU Jia-Qi. Impact of Hyperhomocysteine on Short-Term Outcome in Acute Cerebral Infarction Patients with Non-Valvular Atrial Fibrillation[J]. Chinese Journal of Stroke, 2020, 15(11): 1192-1197.

参考文献

[1] 中国心血管病报告编写组. 《中国心血管病报告

2016》概要[J]. 中国循环杂志，2017，32（6）：521-

530.

[2] CULEBRAS A，MESSÉ S R，CHATURVEDI S，et

al. Summary of evidence-based guideline update：

prevention of stroke in nonvalvular atrial fibrillation：

report of the Guideline Development Subcommittee

of the American Academy of Neurology[J].

Neurology，2014，82（8）：716-724.

[3] LIP G Y. Stroke and bleeding risk assessment in

atrial fibrillation：when，how，and why[J]. Eur Heart

J，2013，34（14）：1041-1049.

[4] JANUARY C T，WANN L S，ALPERT J S，et al.

2014 AHA/ACC/HRS guideline for the management

of patients with atrial fibrillation：a report of the

American College of Cardiology/American Heart

Association Task Force on Practice Guidelines and

the Heart Rhythm Society[J]. J Am Coll Cardiol，

2014，64（21）：2305-2307.

[5] BAGGOTT J E，TAMURA T. Homocysteine，

iron and cardiovascular disease：a hypothesis[J].

Nutrients，2015，7（2）：1108-1118.

[6] SHI Z H，GUAN Y L，HUO Y R，et al. Elevated

total homocysteine levels in acute ischemic stroke

are associated with long-term mortality[J]. Stroke，

2015，46（9）：2419-2425.

[7] 姚艳，赵靖华，冯莉，等. 心房颤动合并脑栓塞患者

血浆同型半胱氨酸的水平及其与 CHA2DS2-VASc 评

分的关系[J]. 中国心脏起搏与心电生理杂，2015，29

（3）：221-223.

[8] 中华医学会神经病学分会，中华医学会神经病学分

会脑血管病学组. 中国急性缺血性脑卒中诊治指南

2014[J]. 中华神经科杂志，2015，48（4）：246-257.

[9] KWON H M，LEE Y S，BAE H J，et al.

Homocysteine as a predictor of early neurological

deterioration in acute ischemic stroke[J]. Stroke，

2014，45（3）：871-873.

[10] YAO E S，TANG Y，XIE M J，et al. Elevated

homocysteine level related to poor outcome after

thrombolysis in acute ischemic stroke[J]. Med Sci

Monit，2016，15（22）：3268-3273.

[11] 郭振方，王桂华，贵永堃，等. 血清Hcy和hs-CRP与

缺血性卒中各亚型关系的临床研究[J]. 中国卒中杂

志，2017，12（12）：1081-1085.

[12] 姚艳，赵靖华，尚美生，等. 同型半胱氨酸与非瓣膜

性心房颤动关系的研究[J]. 心肺血管病杂志，2015，

34（5）：348-350.

[13] WALD D S，LAW M，MORRIS J K. Homocysteine

and cardiovascular disease：evidence on causality

from a meta-analysis[J]. BMJ，2002，325（7374）：

1202-1206.

[14] JEON S B，KANG D W，KIM J S，et al.

Homocysteine，small-vessel disease，and

atherosclerosis：an MRI study of 825 stroke

patients[J]. Neurology，2014，83（8）：695-701.

[15] SCHALINSKE K L，SMAZAL A L. Homocysteine

imbalance：a pathological metabolic marker[J]. Adv

Nutr，2012，3（6）：755-762.

[16] FORD A H，FLICKER L，SINGH U，et al.

Homocysteine，depression and cognitive function in

older adults[J]. J Affect Disord，2013，151（2）：646-

651.

[17] FORD A H，FLICKER L，SINGH U，HIRANI V，et

al. Homocysteine，depression and cognitive function

in older adults[J]. J Affect Disord，2013，151（2）：

646-651.

[18] SPENCE J D. Homocysteine lowering for stroke

prevention：unravelling the complexity of the

evidence[J]. Int J Stroke，2016，11（7）：744 -747.

[19] YAO Y，SHANG M S，GAO L J，et al. Elevated

homocysteine increases the risk of left atrial/left

atrial appendage thrombus in non-valvular atrial

fibrillation with low CHA2DS2-VASc score[J].

Europace，2018，20（7）：1093-1098.

[20] POLI D，ANTONUCCI E，CECCHI E，et al. Culprit

factors for the failure of well-conducted warfarin

therapy to prevent ischemic events in patients with

atrial fibrillation：the role of homocysteine[J]. Stroke，

2005，36（10）：2159-2163.

[21] ABUSHIK P A，NIITTYKOSKI M，

GINIATULLINA R，et al. The role of NMDA and

mGluR5 receptors in calcium mobilization and

neurotoxicity of homocysteine in trigeminal and

cortical neurons and glial cells[J]. J Neurochem，

2014，129（2）：264-274.

[22] CURRO M，GUGLIANDOLO A，GANGEMI C，et

al. Toxic effects of mildly elevated homocysteine

concentrations in neuronal-like cells[J]. Neurochem

Res，2014，39（8）：1485-1495.

[23] KALANI A，KAMAT P K，TYAGI S C，et

al. Synergy of homocysteine，microRNA，and

epigenetics：a novel therapeutic approach for

stroke[J]. Mol Neurobiol，2013，48（1）：157-168.

[24] LAI W K，KAN M Y. Homocysteine-induced

endothelial dysfunction[J]. Ann Nutr Metab，2015，

67（1）：1-12.

[25] PANG X M，LIU J T，ZHAO J J，et al.

Homocysteine induces the expression of C - reactive

protein via NMDAr-ROS-MAPK-NF-κB signal

pathway in rat vascular smooth muscle cells[J].

Atherosclerosis，2014，236（1）：73-81.

[26] DJURIC D，JAKOVLJEVIC V，ZIVKOVIC V，et al.

Homocysteine and homocysteine-related compounds：

an overview of the roles in the pathology of the

cardiovascular and nervous systems[J]. Can J Physiol

Pharmacol，2018，96（10）：991-1003.

[27] MARCUS G M，SMITH L M，ORDOVAS K，et

al. Intracardiac and extracardiac markers of

inflammation during atrial fibrillation[J]. Heart

Rhythm，2010，7（2）：149-154.